Archives
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Necrostatin-1: Advanced RIP1 Kinase Inhibitor Applications i
2026-05-09
Explore how Necrostatin-1, a potent RIP1 kinase inhibitor, empowers researchers to dissect necroptosis and cell death mechanisms beyond standard workflows. This article uniquely connects mechanistic insights with translational assay design and highlights emerging links between necroptosis, ferroptosis, and disease progression.
-
GDC-0941: Potent PI3K Inhibitor for Cancer Pathway Research
2026-05-08
GDC-0941 is a selective, orally bioavailable PI3K inhibitor that targets PI3Kα and PI3Kδ isoforms with nanomolar potency. This compound disrupts the PI3K/Akt pathway, effectively inhibiting cell proliferation in diverse cancer models. Its precise mechanism and robust preclinical performance make it a preferred tool for dissecting oncogenic signaling.
-
CBD Attenuates Orofacial Inflammatory Pain via Endocannabino
2026-05-08
This study provides new evidence that cannabidiol (CBD) robustly reduces both sensory and affective symptoms of orofacial inflammatory pain in mouse models. Mechanistic insights reveal CBD’s dual action on peripheral and central endocannabinoid pathways—specifically CB1 and CB2 receptors—highlighting its translational potential for complex pain and comorbidities.
-
RepSox ALK5 Inhibitor: Advancing iPSC Platelet Production
2026-05-07
RepSox, a potent ALK5 inhibitor, is revolutionizing induced pluripotent stem cell (iPSC) workflows by streamlining reprogramming and facilitating efficient, cost-effective platelet differentiation. Backed by recent protocol optimizations, RepSox enables higher yields and improved reproducibility for translational research in regenerative medicine.
-
Solving Cell Proliferation Challenges with EdU Imaging Kits
2026-05-07
Discover how EdU Imaging Kits (Cy3) (SKU K1075) streamline and strengthen cell proliferation assays for biomedical researchers. This article presents real-world laboratory scenarios, data-driven answers, and protocol guidance, demonstrating the kit’s advantages in sensitivity, workflow safety, and reproducibility for S-phase DNA synthesis measurement. Explore why APExBIO’s EdU Imaging Kits (Cy3) are a trusted choice for robust cell proliferation and genotoxicity testing.
-
Antibacterial Use and Resistance in Psychiatric Hospitals Du
2026-05-06
This study provides a detailed analysis of antibacterial drug utilization and bacterial resistance patterns in a psychiatric hospital during the 2022 COVID-19 epidemic. The findings highlight both the relatively prudent use of antibiotics compared to regional and national benchmarks, and the persistent challenge of rising bacterial resistance, emphasizing the need for rigorous monitoring and targeted antimicrobial stewardship.
-
Canagliflozin Hemihydrate: Precision Tool for Glucose Pathwa
2026-05-06
Unlock advanced glucose metabolism research with Canagliflozin hemihydrate, a high-purity SGLT2 inhibitor. This in-depth analysis reveals new assay considerations and practical insights unavailable in existing guides.
-
Methyl-β-cyclodextrin: Technical Guidance for Membrane Resea
2026-05-05
Methyl-β-cyclodextrin enables precise and reproducible extraction of cholesterol and other lipids from cellular membranes, facilitating studies of membrane fluidity, organization, and lipid raft dynamics. It is strictly intended for laboratory-based research and should not be used for diagnostic or medical applications.
-
Entecavir (BMS200475): Advanced Workflows for HBV Replicatio
2026-05-05
Entecavir (BMS200475) stands out for its potent, selective inhibition of both wild-type and lamivudine-resistant HBV, making it the preferred tool for dissecting chronic hepatitis B virus replication. This guide unlocks step-by-step experimental protocols, comparative advantages, and troubleshooting strategies to maximize reliability and translational impact in HBV research.
-
Enhancing Assay Reliability with SD 169 (indole-5-carboxamid
2026-05-04
This article guides biomedical researchers and lab technicians through real-world challenges in cell viability, apoptosis, and neuroregeneration assays, illustrating how SD 169 (indole-5-carboxamide) (SKU C5850) delivers reproducible, data-backed solutions. Scenario-driven Q&A blocks draw on peer-reviewed data and validated protocols, highlighting the compound’s selectivity, workflow compatibility, and supplier reliability for advanced p38 MAPK pathway interrogation.
-
GDC-0941: PI3K Inhibitor Workflows for Robust Cancer Researc
2026-05-04
GDC-0941, a selective PI3K inhibitor from APExBIO, empowers researchers with reproducible inhibition of the PI3K/Akt pathway across in vitro and in vivo models. This guide delivers stepwise protocols, application-specific troubleshooting, and practical integration of recent reference breakthroughs to elevate oncology assay performance.
-
Applied Workflows with Eicosapentaenoic Acid in Cardiovascul
2026-05-03
Eicosapentaenoic Acid (EPA) stands out as a reproducible EPA omega-3 fatty acid for cardiovascular disease research, providing robust lipid-lowering and anti-inflammatory properties. This article details optimized bench protocols, experimental troubleshooting, and unique cross-domain insights that maximize the value of APExBIO’s high-purity EPA (B3464) in translational workflows.
-
Taraxasterol Suppresses Necroptosis to Reverse BMSC Imbalanc
2026-05-02
The reference study demonstrates that taraxasterol (TAX) alleviates osteoporosis by targeting the PI3K/AKT/PPARγ axis to suppress necroptosis and correct the osteogenic–adipogenic differentiation imbalance in bone marrow mesenchymal stem cells (BMSCs). These findings highlight necroptosis as a modifiable mechanism in osteoporosis and suggest workflow opportunities for necroptosis assay development and RIP1 kinase inhibitor benchmarking.
-
Deferiprone for Iron Modulation: Protocols and Troubleshooti
2026-05-01
Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) enables precise, reproducible control of cellular iron homeostasis in cancer, neurovascular, and enterocyte metabolism research. This guide delivers actionable protocols, advanced workflow refinements, and troubleshooting insights, translating the latest mechanistic findings into laboratory success.
-
Geneticin (G-418 Sulfate): Precision Selection and Antiviral
2026-05-01
Explore the dual power of Geneticin (G418 Sulfate) as both a genetic engineering selection antibiotic and an advanced tool for antiviral research. This article uniquely bridges protein synthesis inhibition with practical assay design, offering new analytical depth and actionable guidance for molecular and cellular biologists.